LALuis Felipe Arias-Ruiz

Luis Felipe Arias-Ruiz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luis Felipe Arias-Ruiz has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pathological and Immunohistochemical Features of Malignant Peripheral Nerve Sheath Tumor With Heterologous Rhabdomy Oblastic Differentiation (Malignant Triton Tumor) in the Context of the Malignant Peripheral Nerve Sheath Tumor Spectrum

    by Luis Felipe Arias-Ruiz, Carlos Ortiz-Hidalgo

    Malignant peripheral nerve sheath tumors (MPNST) are aggressive sarcomas arising from Schwann cells or neurofibromas, comprising ∼10% of soft tissue sarcomas. Found in 8% to 13% of neurofibromatosis type 1 patients, they typically show spindle cells expressing S100 and SOX10. Some display heterologous differentiation (bone, cartilage, vessels, or glands). When rhabdomyosarcomatous features are present, they are called malignant peripheral nerve heath tumor with heterologous rhabdomyoblastic differentiation (malignant triton tumors), which are more prone to recurrence, metastasis, and worse outcomes. Epithelial differentiation does not affect prognosis. Despite advances in understanding MPNST biology, many pathophysiological mechanisms remain unclear. This review highlights their histopathology, focusing on malignant triton tumor.


  • Open Access

    Mechanisms Involved in the Adverse Cardiovascular Effects of Selective Cyclooxygenase-2 Inhibitors

    by Oscar Jesus Leal-Ramos, Luis Felipe Arias-Ruiz, José Miguel Huerta-Velázquez, José Pablo Lamoreaux-Aguayo, Dalton Butcher, Asela Berenice López-Cuellar, Karina Iveth Orozco-Jiménez, Olivia Torres-Bugarín

    Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for managing inflammation, but they are associated with gastrointestinal and renal toxicity upon long-term use. Selective cyclooxygenase-2 (COX-2) inhibitors, or coxibs, were developed to avoid these adverse effects while maintaining anti-inflammatory efficacy. However, accumulating evidence indicates that coxibs may increase the risk of cardiovascular complications. This review explores the pathophysiological mechanisms underlying adverse cardiovascular effects in patients treated with COX-2 inhibitors. These mechanisms include an imbalance between prothrombotic and antithrombotic factors, an altered endocannabinoid metabolism, and downregulation of PPARδ, contributing to thrombosis. Additionally, COX-2 inhibition disrupts renal prostaglandin synthesis, particularly PGE2 and prostacyclins, reduces EP4 receptor expression in macrophages, promotes chemotaxis, and elevates arterial pressure via increased iNOS, ADMA, and L-NMMA activity. At the molecular level, genetic polymorphisms, matrix metalloproteinases, signaling cross-talk, and direct cardiomyocyte injury are implicated. Collectively, these alterations promote a prothrombotic state, fluid retention, enhanced vasoconstriction, impaired vasodilation, myocardial injury, cell death, and cardiac fibrosis. Despite these risks, coxibs are often prescribed without adequate cardiovascular assessment, particularly in patients with pre-existing cardiovascular risk factors. Greater awareness of these mechanisms is essential to optimize the benefit–risk ratio in clinical decision-making involving selective COX-2 inhibitors.


  • Open Access

    Complicated appendicitis as a rare presentation of Burkitt’s lymphoma: a case report

    by Kevin J Fuentes-Calvo, Luis F Arias-Ruiz, Irving Fuentes-Calvo, Angélica D Hidalgo-Maldonado, María F Aparicio-Sosa, Edson Escandón-Villalobos, Luis O González-Alcocer, Oscar Aguilar-Ruiz, Rita Dorantes-Heredia, Gonzalo Torres-Villalobos

    Burkitt lymphoma (BL) is an aggressive B-cell non-Hodgkin lymphoma that rarely involves the appendix and may mimic acute appendicitis, complicating preoperative diagnosis. In the context of nonoperative management for appendicitis, such malignancies risk being overlooked. A 32-year-old immunocompetent male presented with right upper quadrant pain, leukocytosis, cholestatic liver profile, and a hepatic lesion on imaging. Positron emission tomography-computed tomography (PET-CT) showed intense fluorodeoxyglucose uptake in the colon, liver, and peritoneum. Laparoscopy revealed an enlarged appendix (15 × 3 cm) with abscess; appendectomy was performed. Histopathology confirmed BL with a ‘starry sky’ pattern and Ki-67 of 95%. Appendiceal BL, though rare, should be suspected in atypical or complicated appendicitis, even without classic risk factors. Histopathological examination of appendectomy specimens is crucial. Surgery, even when not oncologic in intention, may lead to early cancer detection and timely systemic treatment, improving outcomes.


  • Open Access

    Micronúcleos: Actualización del papel en la inestabilidad genética, inflamación, envejecimiento y cáncer. Revisión panorámica.

    by Olivia Torres-Bugarin, Luis Felipe Arias-Ruiz

    La integridad del genoma es esencial para la salud y la continuidad de las especies. Los micronúcleos son biomarcadores de genotoxicidad, y protagonistas de inestabilidad y caos genético. Un micronúcleo o cuerpo de Howell-Jolly, contiene DNA independiente del núcleo, este se origina por retraso anafásico, cuya membrana es inestable y proclive a romperse sin reparación. El DNA contenido en estas estructuras puede condensarse, replicarse, dividirse, no obstante, de manera asincrónica al material genético nuclear, incluso puede sufrir de cromotripisis y reincorporarse al núcleo, lo cual provoca caos genético y con ello cáncer. Por otro lado, si el DNA del micronúcleo es liberado al citosol, desencadena la respuesta inflamatoria crónica, senescencia y apoptosis. Entonces, es vital detectar oportunamente a individuos susceptibles al daño genómico, lo cual permitiría priorizar la atención profiláctica. Por tanto, el objetivo fue hacer una revisión descriptiva sobre algunos de los modelos más empleados e innovadores en la prueba de micronúcleos y los avances celulares y moleculares, en el conocimiento de estas estructuras, así como sus efectos a la salud, para delinear una perspectiva y proponerlos como alternativa preventiva de fácil ejecución en la detección de individuos vulnerables a genotóxicos. Se buscaron artículos en MEDLIANE publicados en los años 2000-2023, que incluían los términos “micronuclei uses and causes” y “micronuclei causes and consecuences”. La inclusión final se determinó después de la revisión de los resúmenes y el posterior análisis del texto completo; se dejaron de incluir artículos una vez que fueron repetitivas las aportaciones.


  • Open Access

    Silver nanoparticles induce a non-immunogenic tumor cell death

    by Maritza Roxana Garcia Garcia, Noelia Casares, Luz Andrea Martinez Perez, Efren Juarez Curiel, Andres Alberto de Jesus Hernandez, Nina Bogdanchikova, Diana Garibo, Ana G. Rodriguez-Hernandez, Alexey Pestryakov, Sandra Castro Gamboa, et al.

    Immunogenic cell death (ICD) is a form of cell death characterized by the release of danger signals required to trigger an adaptive immune response against tumor-associated antigens. Silver nanoparticles (AgNP) display anti-proliferative and cytotoxic effects in tumor cells, but it has not been previously studied whether AgNP act as an ICD inductor. The present study evaluated the in vitro release of calreticulin as a damage-associated molecular pattern (DAMP) associated with the cytotoxicity of AgNP and their in vivo anti-cancer effects. In vitro, mouse CT26 colon carcinoma and MCA205 fibrosarcoma cells were exposed to AgNP and then cell proliferation, adhesion, and release of calreticulin were determined. The results indicated there were time- and concentration-related anti-proliferative effects of AgNP in both the CT26 and MCA205 lines. Concurrently, changes in cell adhesion were detected mainly in the CT26 cells. Regarding DAMP detection, a significant increase in calreticulin was observed only in CT26 cells treated with doxorubicin and AgNP; however, no differences were found in the MCA205 cells. In vivo, the survival and growth of subcutaneous tumors were monitored after vaccination of mice with cell debris from tumor cells treated with AgNP or after intra-tumoral administration of AgNP to established tumors. Consequently, anti-tumoral prophylactic immunization with AgNP-dead cells failed to protect mice from tumor re-challenge; intra-tumor injection of AgNP did not induce a significant effect. In conclusion, there was a noticeable anti-tumoral effect of AgNP in vitro in both CT26 and MCA205 cell lines, accompanied by the release of calreticulin in CT26 cells. In vivo, immunization with cell debris derived from AgNP-treated tumor cells failed to induce a protective immune response in the cancer model mice. Clearly, further research is needed to determine if one could combine AgNP with other ICD inducers to improve the anti-tumor effect of these nanoparticles in vivo.


  • Open Access

    Trascendencia del microquimerismo fetal en las enfermedades autoinmunes

    by Luis Felipe Arias-Ruiz, Javier Contreras-Cárdenas, Pablo Mondragón-Ratkovich, María Luisa Ramos-Ibarra, Olivia Torres-Bugarin

    Con frecuencia durante el embarazo ocurre exportación de células, algunas del sistema inmune, tanto de la madre al feto como del feto a la madre. Éstas pueden ser células madre que al cruzar la barrera placentaria e ingresar al cuerpo del anfitrión pueden instalarse en distintos órganos y persistir por décadas. Así, un individuo podría poseer una pequeña población de células y por ende ácidos nucleicos de otro genéticamente diferente. A este fenómeno se le conoce como microquimerismo (MC). Las consecuencias del MC no están claras, pero se plantea que podría tener efectos benéficos, dañinos o podría ser que no tenga efecto alguno, inclusive pudiera ser que estas tres hipótesis no sean mutuamente excluyentes, todo según las circunstancias. Por otro lado, las mujeres en edad fértil tienen mayor riesgo que los hombres de desarrollar alguna enfermedad autoinmune, y este riesgo es significativamente mayor en el primer año posterior al parto. Existen evidencias de que el MC puede estar asociado al desarrollo de algunas enfermedades autoinmunes, debido a que las células T inmaduras quiméricas dentro de los tejidos del anfitrión podrían activarse y liberar citocinas inflamatorias y quimiocinas que están involucradas en los procesos de autoinmunidad. El objetivo de este trabajo es mostrar las evidencias que apoyan la teoría de que el MC está relacionado con este grupo de enfermedades como el síndrome de Sjögren, esclerosis sistémica, lupus eritematoso sistémico y artritis reumatoide.